DNA tumour viruses promote tumour cell invasion and metastasis by deregulating the normal processes of cell adhesion and motility

European Journal of Cell Biology

Volumn 87, Issue 8-9, 2008, Pages 677-697

  Morris, Mhairi A ^a   Young, Lawrence S ^a   Dawson, Christopher W ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adhesion; Cytoskeleton; Integrins; Invasiveness; Matrix metalloproteases; Metastasis; Motility; Tumour virus

Indexed keywords

ACTIN; CD51 ANTIGEN; CELL ADHESION MOLECULE; FLICE INHIBITORY PROTEIN; HEPATITIS B VIRUS X PROTEIN; PROTEIN E5; PROTEIN E6; PROTEIN E7; PROTEIN EBNA1; PROTEIN EBNA3C; PROTEIN GB; PROTEIN LMP1; PROTEIN LMP2A; VIRUS PROTEIN;

CANCER CELL; CANCER INCIDENCE; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL INTERACTION; CELL INVASION; CELL MOTILITY; CELL TRANSFORMATION; CYTOSKELETON; DNA MODIFICATION; DNA VIRUS; EPITHELIUM; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EXTRACELLULAR MATRIX; HEPADNAVIRUS; HEPATITIS B VIRUS; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 8; LEUKEMIA; LIVER CELL CARCINOMA; LYMPHOMA; METASTASIS; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; TIGHT JUNCTION; VERRUCA VULGARIS; VIRUS INFECTION; WART VIRUS;

ANIMALS; CELL ADHESION; CELL MOVEMENT; DNA TUMOR VIRUSES; EXTRACELLULAR MATRIX; HEPATITIS B VIRUS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS;

HEPADNAVIRIDAE; HERPESVIRIDAE; PAPILLOMAVIRIDAE; POLYOMAVIRUS;

EID: 49049103338     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2008.03.005     Document Type: Short Survey

References (229)

1. Akula S.M., Pramod N.P., Wang F.Z., and Chandran B. Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108 (2002) 407-419
2. Akula S.M., Naranatt P.P., Walia N.S., Wang F.Z., Fegley B., and Chandran B. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J. Virol. 77 (2003) 7978-7990
3. Albelda S.M., Mette S.A., Elder D.E., Stewart R., Damjanovich L., Herlyn M., and Buck C.A. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 50 (1990) 6757-6764
4. Allen M.D., Young L.S., and Dawson C.W. The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. J. Virol. 79 (2005) 1789-1802
5. Ambach A., Saunus J., Konstandin M., Wesselborg S., Meuer S.C., and Samstag Y. The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes. Eur. J. Immunol. 30 (2000) 3422-3431
6. Antman K., and Chang Y. Kaposi's sarcoma. N. Engl. J. Med. 342 (2000) 1027-1038
7. Aplin A.E., Howe A., Alahari S.K., and Juliano R.L. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev. 50 (1998) 197-263
8. Arai I., Nagano H., Kondo M., Yamamoto H., Hiraoka N., Sugita Y., Ota H., Yoshioka S., Nakamura M., Wada H., Damdinsuren B., Kato H., Marubashi S., Miyamoto A., Takeda Y., Dono K., Umeshita K., Nakamori S., Wakasa K., Sakon M., and Monden M. Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion. Hepatogastroenterology 54 (2007) 167-171
9. Arroyo J.D., and Hahn W.C. Involvement of PP2A in viral and cellular transformation. Oncogene 24 (2005) 7746-7755
10. Azzam H.S., Arand G., Lippman M.E., and Thompson E.W. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J. Natl. Cancer Inst. 85 (1993) 1758-1764
11. Balbin M., Fueyo A., Tester A.M., Pendas A.M., Pitiot A.S., Astudillo A., Overall C.M., Shapiro S.D., and Lopez-Otin C. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet. 35 (2003) 252-257
12. Baldus S.E., Engelmann K., and Hanisch F.G. MUC1 and the MUCs: a family of human mucins with impact in cancer biology. Crit. Rev. Clin. Lab. Sci. 41 (2004) 189-231
13. Behren A., Simon C., Schwab R.M., Loetzsch E., Brodbeck S., Huber E., Stubenrauch F., Zenner H.P., and Iftner T. Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway. Cancer Res. 65 (2005) 11613-11621
14. Ben-Ze'ev A., Rodriguez Fernandez J.L., Gluck U., Salomon D., and Geiger B. Changes in adhesion plaque protein levels regulate cell motility and tumorigenicity. Adv. Exp. Med. Biol. 358 (1994) 147-157
15. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., and Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2 (2000) 737-744
16. Bouchard M.J., and Schneider R.J. The enigmatic X gene of hepatitis B virus. J. Virol. 78 (2004) 12725-12734
17. Bouvard V., Matlashewski G., Gu Z.M., Storey A., and Banks L. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology 203 (1994) 73-80
18. Bowman E.J., Siebers A., and Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA 85 (1988) 7972-7976
19. Brady-Kalnay S.M., Soll D.R., and Brackenbury R. Invasion of Rous sarcoma virus-transformed retinal cells: role of cell motility. Int. J. Cancer 47 (1991) 560-568
20. Brechot C., Gozuacik D., Murakami Y., and Paterlini-Brechot P. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin. Cancer Biol. 10 (2000) 211-231
21. Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., and Cheresh D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85 (1996) 683-693
22. Brooks P.C., Klemke R.L., Schon S., Lewis J.M., Schwartz M.A., and Cheresh D.A. Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. J. Clin. Invest. 99 (1997) 1390-1398
23. Busk M., Pytela R., and Sheppard D. Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. J. Biol. Chem. 267 (1992) 5790-5796
24. Byers H.R., Etoh T., Doherty J.R., Sober A.J., and Mihm Jr. M.C. Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am. J. Pathol. 139 (1991) 423-435
25. Carragher N.O., Levkau B., Ross R., and Raines E.W. Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin. J. Cell Biol. 147 (1999) 619-630
26. Carragher N.O., Fincham V.J., Riley D., and Frame M.C. Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J. Biol. Chem. 276 (2001) 4270-4275
27. Chambers A.F., and Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89 (1997) 1260-1270
28. Chan A.S., To K.F., Lo K.W., Mak K.F., Pak W., Chiu B., Tse G.M., Ding M., Li X., Lee J.C., and Huang D.P. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res. 60 (2000) 5365-5370
29. Chan C.F., Yau T.O., Jin D.Y., Wong C.M., Fan S.T., and Ng I.O. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Clin. Cancer Res. 10 (2004) 4140-4149
30. Chan G.G., Tai B.C., Liang S., Lim D.T., and Soo K.C. Squamous cell carcinoma of the head and neck (HNSCC) - multi-modality treatment and impact on survival. Asian J. Surg. 25 (2002) 35-40
31. Charo I.F., Nannizzi L., Smith J.W., and Cheresh D.A. The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J. Cell Biol. 111 (1990) 2795-2800
32. Chen S.L., Tsai T.Z., Han C.P., and Tsao Y.P. Mutational analysis of human papillomavirus type 11 E5a oncoprotein. J. Virol. 70 (1996) 3502-3508
33. Choudhuri T., Verma S.C., Lan K., and Robertson E.S. Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors. Virology 351 (2006) 58-72
34. Christofori G., and Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci. 24 (1999) 73-76
35. Chung T.W., Lee Y.C., and Kim C.H. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J. 18 (2004) 1123-1125
36. Conrad M., Bubb V.J., and Schlegel R. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67 (1993) 6170-6178
37. Cougot D., Neuveut C., and Buendia M.A. HBV induced carcinogenesis. J. Clin. Virol. 34 Suppl. 1 (2005) S75-S78
38. Coussens L.M., and Werb Z. Matrix metalloproteinases and the development of cancer. Chem. Biol. 3 (1996) 895-904
39. Coussens L.M., Tinkle C.L., Hanahan D., and Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103 (2000) 481-490
40. Cuevas B.D., Winter-Vann A.M., Johnson N.L., and Johnson G.L. MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer. Oncogene 25 (2006) 4998-5010
41. Damania B. DNA tumor viruses and human cancer. Trends Microbiol. 15 (2007) 38-44
42. Dawson C.W., Rickinson A.B., and Young L.S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344 (1990) 777-780
43. Dawson C.W., Tramountanis G., Eliopoulos A.G., and Young L.S. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J. Biol. Chem. 278 (2003) 3694-3704
44. Dawson C.W., Laverick L., Morris M.A., Tramoutanis G., and Young L.S. Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J. Virol. 82 (2008) 3654-3664
45. De Corte V., Bruyneel E., Boucherie C., Mareel M., Vandekerckhove J., and Gettemans J. Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO J. 21 (2002) 6781-6790
46. Denhardt D.T., and Guo X. Osteopontin: a protein with diverse functions. FASEB J. 7 (1993) 1475-1482
47. Dilworth S.M. Polyoma virus middle T antigen and its role in identifying cancer-related molecules. Nat. Rev. Cancer 2 (2002) 951-956
48. Diwan A.H., Honkanen R.E., Schaeffer Jr. R.C., Strada S.J., and Thompson W.J. Inhibition of serine-threonine protein phosphatases decreases barrier function of rat pulmonary microvascular endothelial cells. J. Cell. Physiol. 171 (1997) 259-270
49. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., Westra W.H., and Gillison M.L. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356 (2007) 1944-1956
50. Fafeur V., Tulasne D., Queva C., Vercamer C., Dimster V., Mattot V., Stehelin D., Desbiens X., and Vandenbunder B. The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells. Cell Growth Differ. 8 (1997) 655-665
51. Fahraeus R., Rymo L., Rhim J.S., and Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345 (1990) 447-449
52. Fahraeus R., Chen W., Trivedi P., Klein G., and Obrink B. Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int. J. Cancer 52 (1992) 834-838
53. Farwell D.G., McDougall J.K., and Coltrera M.D. Expression of Epstein-Barr virus latent membrane proteins leads to changes in keratinocyte cell adhesion. Ann. Otol. Rhinol. Laryngol. 108 (1999) 851-859
54. Fehrmann F., Klumpp D.J., and Laimins L.A. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J. Virol. 77 (2003) 2819-2831
55. Filardo E.J., Brooks P.C., Deming S.L., Damsky C., and Cheresh D.A. Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J. Cell Biol. 130 (1995) 441-450
56. Fogar P., Basso D., Pasquali C., De Paoli M., Sperti C., Roveroni G., Pedrazzoli S., and Plebani M. Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias. Anticancer Res. 17 (1997) 1227-1230
57. Forgac M. Structure, function and regulation of the coated vesicle V-ATPase. J. Exp. Biol. 172 (1992) 155-169
58. Fukuda M., and Longnecker R. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt pathway. J. Virol. 81 (2007) 9299-9306
59. Gendler S.J. MUC1, the renaissance molecule. J. Mammary Gland Biol. Neoplasia 6 (2001) 339-353
60. Genther S.M., Sterling S., Duensing S., Munger K., Sattler C., and Lambert P.F. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J. Virol. 77 (2003) 2832-2842
61. Genther Williams S.M., Disbrow G.L., Schlegel R., Lee D., Threadgill D.W., and Lambert P.F. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res. 65 (2005) 6534-6542
62. Giannelli G., Bergamini C., Marinosci F., Fransvea E., Quaranta M., Lupo L., Schiraldi O., and Antonaci S. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int. J. Cancer 97 (2002) 425-431
63. Gilles C., Polette M., Piette J., Munaut C., Thompson E.W., Birembaut P., and Foidart J.M. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int. J. Cancer 65 (1996) 209-213
64. Gilles C., Polette M., Birembaut P., Brünner N., and Thompson E.W. Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines. Clin. Exp. Metastasis 15 (1997) 519-526
65. Gires O., Zimber-Strobl U., Gonnella R., Ueffing M., Marschall G., Zeidler R., Pich D., and Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16 (1997) 6131-6140
66. Glading A., Uberall F., Keyse S.M., Lauffenburger D.A., and Wells A. Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J. Biol. Chem. 276 (2001) 23341-23348
67. Gou X.M., Chen Y., Chen X.Y., and Arrand J.R. Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1. Ai Zheng 22 (2003) 481-485 (Article in Chinese)
68. Graessmann A., Graessmann M., Tjian R., and Topp W.C. Simian virus 40 small-t protein is required for loss of actin cable networks in rat cells. J. Virol. 33 (1980) 1182-1191
69. Gravdal K., Halvorsen O.J., Haukaas S.A., and Akslen L.A. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin. Cancer Res. 13 (2007) 7003-7011
70. Grossmann C., Podgrabinska S., Skobe M., and Ganem D. Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J. Virol. 80 (2006) 7179-7185
71. Harwood C.A., Surentheran T., McGregor J.M., Spink P.J., Leigh I.M., Breuer J., and Proby C.M. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J. Med. Virol. 61 (2000) 289-297
72. Hawley-Nelson P., Vousden K.H., Hubbert N.L., Lowy D.R., and Schiller J.T. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8 (1989) 3905-3910
73. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153 (1998) 333-339
74. Hirohashi S., and Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 94 (2003) 575-581
75. Horikawa T., Sheen T.S., Takeshita H., Sato H., Furukawa M., and Yoshizaki T. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am. J. Pathol. 159 (2001) 27-33
76. Horikawa T., Yang J., Kondo S., Yoshizaki T., Joab I., Furukawa M., and Pagano J.S. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 67 (2007) 1970-1978
77. Hu L.F., Chen F., Zhen Q.F., Zhang Y.W., Luo Y., Zheng X., Winberg G., Ernberg I., and Klein G. Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. Eur. J. Cancer 31A (1995) 658-660
78. Huang S., Stupack D., Liu A., Cheresh D., and Nemerow G.R. Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of alpha(v) integrins. Oncogene 19 (2000) 1915-1923
79. Huber M.A., Kraut N., and Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17 (2005) 548-558
80. Huttenlocher A., Palecek S.P., Lu Q., Zhang W., Mellgren R.L., Lauffenburger D.A., Ginsberg M.H., and Horwitz A.F. Regulation of cell migration by the calcium-dependent protease calpain. J. Biol. Chem. 272 (1997) 32719-32722
81. Hwang E.S., Nottoli T., and Dimaio D. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 211 (1995) 227-233
82. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69 (1992) 11-25
83. Iftner A., Klug S.J., Garbe C., Blum A., Stancu A., Wilczynski S.P., and Iftner T. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res. 63 (2003) 7515-7519
84. Janes S.M., and Watt F.M. Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J. Cell Biol. 166 (2004) 419-431
85. Janssens V., and Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353 (2001) 417-439
86. Janssens V., Goris J., and Van Hoof C. PP2A: the expected tumor suppressor. Curr. Opin. Genet. Dev. 15 (2005) 34-41
87. Jia L., Wang X.W., and Harris C.C. Hepatitis B virus X protein inhibits nucleotide excision repair. Int. J. Cancer 80 (1999) 875-879
88. Johansson S., Svineng G., Wennerberg K., Armulik A., and Lohikangas L. Fibronectin-integrin interactions. Front. Biosci. 2 (1997) d126-d146
89. Johnsen M., Lund L.R., Romer J., Almholt K., and Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 10 (1998) 667-671
90. Johnson J.P. Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease. Cancer Metastasis Rev. 10 (1991) 11-22
91. Jussila L., Valtola R., Partanen T.A., Salven P., Heikkila P., Matikainen M.T., Renkonen R., Kaipainen A., Detmar M., Tschachler E., Alitalo R., and Alitalo K. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58 (1998) 1599-1604
92. Kanai Y., Ushijima S., Hui A.M., Ochiai A., Tsuda H., Sakamoto M., and Hirohashi S. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer 71 (1997) 355-359
93. Kang Y., and Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118 (2004) 277-279
94. Kaye K.M., Izumi K.M., and Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90 (1993) 9150-9154
95. Kieff E., and Rickinson A.B. Epstein-Barr virus and its replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 4th ed (2001), Lippincott Williams & Wilkins, Philadelphia 2511-2574
96. Kim C.M., Koike K., Saito I., Miyamura T., and Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351 (1991) 317-320
97. Kim K.R., Yoshizaki T., Miyamori H., Hasegawa K., Horikawa T., Furukawa M., Harada S., Seiki M., and Sato H. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 19 (2000) 1764-1771
98. Kim Y.S., Gum Jr. J., and Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj. J. 13 (1996) 693-707
99. Kivi N., Greco D., Auvinen P., and Auvinen E. Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression. Oncogene (2007) 10.1038/sj.onc.1210916 (Epub ahead of print)
100. Klein N.P., Bouchard M.J., Wang L.H., Kobarg C., and Schneider R.J. Src kinases involved in hepatitis B virus replication. EMBO J. 18 (1999) 5019-5027
101. Kola I., Brookes S., Green A.R., Garber R., Tymms M., Papas T.S., and Seth A. The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc. Natl. Acad. Sci. USA 90 (1993) 7588-7592
102. Kondo S., Wakisaka N., Schell M.J., Horikawa T., Sheen T.S., Sato H., Furukawa M., Pagano J.S., and Yoshizaki T. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int. J. Cancer 115 (2005) 368-376
103. Kondo S., Seo S.Y., Yoshizaki T., Wakisaka N., Furukawa M., Joab I., Jang K.L., and Pagano J.S. EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res. 66 (2006) 9870-9877
104. Kondo S., Yoshizaki T., Wakisaka N., Horikawa T., Murono S., Jang K.L., Joab I., Furukawa M., and Pagano J.S. MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling. J. Virol. 81 (2007) 1554-1562
105. Krishna S.M., Kattoor J., and Balaram P. Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas. Cancer Biomark 1 (2005) 271-277
106. Kroczynska B., Cutrone R., Bocchetta M., Yang H., Elmishad A.G., Vacek P., Ramos-Nino M., Mossman B.T., Pass H.I., and Carbone M. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc. Natl. Acad. Sci. USA 103 (2006) 14128-14133
107. Lara-Pezzi E., Majano P.L., Yanez-Mo M., Gomez-Gonzalo M., Carretero M., Moreno-Otero R., Sanchez-Madrid F., and Lopez-Cabrera M. Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J. Hepatol. 34 (2001) 409-415
108. Lara-Pezzi E., Serrador J.M., Montoya M.C., Zamora D., Yanez-Mo M., Carretero M., Furthmayr H., Sanchez-Madrid F., and Lopez-Cabrera M. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis. Hepatology 33 (2001) 1270-1281
109. Lara-Pezzi E., Gomez-Gaviro M.V., Galvez B.G., Mira E., Iniguez M.A., Fresno M., Martinez A.C., Arroyo A.G., and Lopez-Cabrera M. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J. Clin. Invest. 110 (2002) 1831-1838
110. Lee J.O., Kwun H.J., Jung J.K., Choi K.H., Min D.S., and Jang K.L. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 24 (2005) 6617-6625
111. Lee M.J., Lee H.S., Kim W.H., Choi Y., and Yang M. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod. Pathol. 16 (2003) 403-410
112. Lee S.G., and Rho H.M. Transcriptional repression of the human p53 gene by hepatitis B viral X protein. Oncogene 19 (2000) 468-471
113. Leechanachai P., Banks L., Moreau F., and Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 7 (1992) 19-25
114. Leira F., Alvarez C., Vieites J.M., Vieytes M.R., and Botana L.M. Study of cytoskeletal changes induced by okadaic acid in BE(2)-M17 cells by means of a quantitative fluorimetric microplate assay. Toxicol. In Vitro 15 (2001) 277-282
115. Lester B.R., and McCarthy J.B. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Rev. 11 (1992) 31-44
116. Li H.P., and Chang Y.S. Epstein-Barr virus latent membrane protein 1: structure and functions. J. Biomed. Sci. 10 (2003) 490-504
117. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., and Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284 (1980) 67-68
118. Liu Z.Y., Ganju R.K., Wang J.F., Ona M.A., Hatch W.C., Zheng T., Avraham S., Gill P., and Groopman J.E. Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. J. Clin. Invest. 99 (1997) 1798-1804
119. Liu Z.Y., Ganju R.K., Wang J.F., Schweitzer K., Weksler B., Avraham S., and Groopman J.E. Characterization of signal transduction pathways in human bone marrow endothelial cells. Blood 90 (1997) 2253-2259
120. Lo A.K., Liu Y., Wang X.H., Huang D.P., Yuen P.W., Wong Y.C., and Tsao G.S. Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1. Lab. Invest. 83 (2003) 697-709
121. Longnecker R. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?. Adv. Cancer Res 79 (2000) 175-200
122. Longnecker R., Druker B., Roberts T.M., and Kieff E. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J. Virol. 65 (1991) 3681-3692
123. Lu J., Lin W.H., Chen S.Y., Longnecker R., Tsai S.C., Chen C.L., and Tsai C.H. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J. Biol. Chem. 281 (2006) 8806-8814
124. Macias-Silva M., and Garcia-Sainz J.A. Inhibition of hormone-stimulated inositol phosphate production and disruption of cytoskeletal structure. Effects of okadaic acid, microcystin, chlorpromazine, W7 and nystatin. Toxicon 32 (1994) 105-112
125. Mainou B.A., Everly Jr. D.N., and Raab-Traub N. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24 (2005) 6917-6924
126. Mainou B.A., Everly Jr. D.N., and Raab-Traub N. Unique signaling properties of CTAR1 in LMP1-mediated transformation. J. Virol. 81 (2007) 9680-9692
127. Mantovani F., Massimi P., and Banks L. Proteasome-mediated regulation of the hDlg tumour suppressor protein. J. Cell Sci. 114 (2001) 4285-4292
128. Marchio S., Primo L., Pagano M., Palestro G., Albini A., Veikkola T., Cascone I., Alitalo K., and Bussolino F. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. J. Biol. Chem. 274 (1999) 27617-27622
129. Martinez-Zaguilan R., Lynch R.M., Martinez G.M., and Gillies R.J. Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am. J. Physiol. 265 (1993) C1015-C1029
130. McLaughlin-Drubin M.E., and Munger K. Viruses associated with human cancer. Biochim. Biophys. Acta 1782 (2008) 127-150
131. Mileo A.M., Piombino E., Severino A., Tritarelli A., Paggi M.G., and Lombardi D. Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein. J. Bioenerg. Biomembr. 38 (2006) 215-225
132. Miller C.L., Lee J.H., Kieff E., Burkhardt A.L., Bolen J.B., and Longnecker R. Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction. Infect. Agents Dis. 3 (1994) 128-136
133. Moore P.S., and Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?. Annu. Rev. Microbiol. 57 (2003) 609-639
134. Moreno C.S., Ramachandran S., Ashby D.G., Laycock N., Plattner C.A., Chen W., Hahn W.C., and Pallas D.C. Signaling and transcriptional changes critical for transformation of human cells by Simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdown. Cancer Res. 64 (2004) 6978-6988
135. Munger K., Phelps W.C., Bubb V., Howley P.M., and Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63 (1989) 4417-4421
136. Munoz N., Bosch F.X., Castellsague X., Diaz M., de Sanjose S., Hammouda D., Shah K.V., and Meijer C.J. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int. J. Cancer 111 (2004) 278-285
137. Murakami M., Lan K., Subramanian C., and Robertson E.S. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J. Virol. 79 (2005) 1559-1568
138. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J. Gastroenterol. 36 (2001) 651-660
139. Murono S., Inoue H., Tanabe T., Joab I., Yoshizaki T., Furukawa M., and Pagano J.S. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc. Natl. Acad. Sci. USA 98 (2001) 6905-6910
140. Nakada M., Yamashita J., Okada Y., and Sato H. Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors. J. Neuropathol. Exp. Neurol. 58 (1999) 329-334
141. Nakayama T., Ito M., Ohtsuru A., Naito S., Nakashima M., Fagin J.A., Yamashita S., and Sekine I. Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion. Am. J. Pathol. 149 (1996) 1931-1939
142. Niggli V., Djafarzadeh S., and Keller H. Stimulus-induced selective association of actin-associated proteins (alpha-actinin) and protein kinase C isoforms with the cytoskeleton of human neutrophils. Exp. Cell Res. 250 (1999) 558-568
143. Nip J., Rabbani S.A., Shibata H.R., and Brodt P. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. J. Clin. Invest. 95 (1995) 2096-2103
144. Nunbhakdi-Craig V., Machleidt T., Ogris E., Bellotto D., White III C.L., and Sontag E. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J. Cell Biol. 158 (2002) 967-978
145. Nunbhakdi-Craig V., Craig L., Machleidt T., and Sontag E. Simian virus 40 small tumor antigen induces deregulation of the actin cytoskeleton and tight junctions in kidney epithelial cells. J. Virol. 77 (2003) 2807-2818
146. Nuovo G.J., MacConnell P.B., Simsir A., Valea F., and French D.L. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 55 (1995) 267-275
147. Oelze I., Kartenbeck J., Crusius K., and Alonso A. Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J. Virol. 69 (1995) 4489-4494
148. Okada T., Narai A., Matsunaga S., Fusetani N., and Shimizu M. Assessment of the marine toxins by monitoring the integrity of human intestinal Caco-2 cell monolayers. Toxicol. In Vitro 14 (2000) 219-226
149. O'Shea C.C. DNA tumor viruses - the spies who lyse us. Curr. Opin. Genet. Dev. 15 (2005) 18-26
150. Ou D.P., Tao Y.M., Chang Z.G., Tang F.Q., and Yang L.Y. Hepatocellular carcinoma cells containing hepatitis B virus X protein have enhanced invasive potential conditionally. Dig. Liver Dis. 38 (2006) 262-267
151. Pagano J.S., Blaser M., Buendia M.A., Damania B., Khalili K., Raab-Traub N., and Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin. Cancer Biol. 14 (2004) 453-471
152. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118 (2006) 3030-3044
153. Paulus W., Baur I., Huettner C., Schmausser B., Roggendorf W., Schlingensiepen K.H., and Brysch W. Effects of transforming growth factor-beta 1 on collagen synthesis, integrin expression, adhesion and invasion of glioma cells. J. Neuropathol. Exp. Neurol. 54 (1995) 236-244
154. Pegtel D.M., Subramanian A., Sheen T.S., Tsai C.H., Golub T.R., and Thorley-Lawson D.A. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J. Virol. 79 (2005) 15430-15442
155. Pershouse M.A., Heivly S., and Girtsman T. The role of SV40 in malignant mesothelioma and other human malignancies. Inhal. Toxicol. 18 (2006) 995-1000
156. Bouvard V., Matlashewski G., Gu Z.M., Storey A., and Banks L. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology 203 (1994) 73-80
157. Pisani S., Fioriti D., Conte M.P., Chiarini F., Seganti L., and Degener A.M. Involvement of herpes simplex type 2 in modulation of gene expression of human papillomavirus type 18. Int. J. Immunopathol. Pharmacol. 15 (2002) 59-63
158. Puls A., Eliopoulos A.G., Nobes C.D., Bridges T., Young L.S., and Hall A. Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF(alpha) and IL-1, and by the Epstein-Barr virus transforming protein LMP1. J. Cell Sci. 112 (1999) 2983-2992
159. Pytela R., Pierschbacher M.D., and Ruoslahti E. A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc. Natl. Acad. Sci. USA 82 (1985) 5766-5770
160. Queva C., Leprince D., Stehelin D., and Vandenbunder B. p54c-ets-1 and p68c-ets-1, the two transcription factors encoded by the c-ets-1 locus, are differentially expressed during the development of the chick embryo. Oncogene 8 (1993) 2511-2520
161. Rao J., and Li N. Microfilament actin remodeling as a potential target for cancer drug development. Curr. Cancer Drug Targets 4 (2004) 345-354
162. Ringel J., and Lohr M. The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Mol. Cancer 2 (2003) 9
163. Romashko A.A., and Young M.R. Protein phosphatase-2A maintains focal adhesion complexes in keratinocytes and the loss of this regulation in squamous cell carcinomas. Clin. Exp. Metastasis 21 (2004) 371-379
164. Schafer D.F., and Sorrell M.F. Hepatocellular carcinoma. Lancet 353 (1999) 1253-1257
165. Scholle F., Longnecker R., and Raab-Traub N. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase. J. Virol. 73 (1999) 4767-4775
166. Scholle F., Bendt K.M., and Raab-Traub N. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates. Akt. J. Virol. 74 (2000) 10681-10689
167. Shamanin V., zur Hausen H., Lavergne D., Proby C.M., Leigh I.M., Neumann C., Hamm H., Goos M., Haustein U.F., Jung E.G., Plewig G., Wolff H., and de Villiers E.M. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J. Natl. Cancer Inst. 88 (1996) 802-811
168. Sheu L.F., Chen A., Meng C.L., Ho K.C., Lee W.H., Leu F.J., and Chao C.F. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. J. Pathol. 180 (1996) 243-248
169. 2+-dependent neutral protease (calpain) activity in breast cancer tissue and estrogen receptor status. Breast Cancer 3 (1996) 13-17
170. Shirakata Y., Kawada M., Fujiki Y., Sano H., Oda M., Yaginuma K., Kobayashi M., and Koike K. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn. J. Cancer Res. 80 (1989) 617-621
171. Simon C., Hicks M.J., Nemechek A.J., Mehta R., O'Malley Jr. B.W., Goepfert H., Flaitz C.M., and Boyd D. PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma. Br. J. Cancer 80 (1999) 1412-1419
172. Simon C., Simon M., Vucelic G., Hicks M.J., Plinkert P.K., Koitschev A., and Zenner H.P. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp. Cell Res. 271 (2001) 344-355
173. Singer K.L., Stevenson B.R., Woo P.L., and Firestone G.L. Relationship of serine/threonine phosphorylation/dephosphorylation signaling to glucocorticoid regulation of tight junction permeability and ZO-1 distribution in nontransformed mammary epithelial cells. J. Biol. Chem. 269 (1994) 16108-16115
174. Smith J.W., and Cheresh D.A. Getting unglued about integrins. The Molecular Basis of Cellular Adhesion: A UCLA symposium, Sponsored by Genentech and Glaxo Steamboat Springs, CO, USA, January 20-26, 1990. New Biol. 2 (1990) 518-522
175. Smith J.W., Ruggeri Z.M., Kunicki T.J., and Cheresh D.A. Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites. J. Biol. Chem. 265 (1990) 12267-12271
176. Smola-Hess S., Schnitzler R., Hadaschik D., Smola H., Mauch C., Krieg T., and Pfister H. CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-kappaB and STAT3 activation. Exp. Cell Res. 267 (2001) 205-215
177. Smola-Hess S., Pahne J., Mauch C., Zigrino P., Smola H., and Pfister H.J. Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. J. Gen. Virol. 86 (2005) 1291-1296
178. Sontag J.M., and Sontag E. Regulation of cell adhesion by PP2A and SV40 small tumor antigen: an important link to cell transformation. Cell. Mol. Life Sci. 63 (2006) 2979-2991
179. Stanton H., Gavrilovic J., Atkinson S.J., d'Ortho M.P., Yamada K.M., Zardi L., and Murphy G. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J. Cell Sci. 111 (1998) 2789-2798
180. Stoppler M.C., Straight S.W., Tsao G., Schlegel R., and McCance D.J. The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology 223 (1996) 251-254
181. Straight S.W., Hinkle P.M., Jewers R.J., and McCance D.J. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67 (1993) 4521-4532
182. Straight S.W., Herman B., and McCance D.J. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J. Virol. 69 (1995) 3185-3192
183. Strathdee G. Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin. Cancer Biol. 12 (2002) 373-379
184. Subramanian C., Cotter II M.A., and Robertson E.S. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat. Med. 7 (2001) 350-355
185. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251 (1991) 1451-1455
186. Talis A.L., Huibregtse J.M., and Howley P.M. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J. Biol. Chem. 273 (1998) 6439-6445
187. Talwalkar J.A., and Gores G.J. Diagnosis and staging of hepatocellular carcinoma. Gastroenterology 127 (2004) S126-S132
188. Tar K., Csortos C., Czikora I., Olah G., Ma S.F., Wadgaonkar R., Gergely P., Garcia J.G., and Verin A.D. Role of protein phosphatase 2A in the regulation of endothelial cell cytoskeleton structure. J. Cell. Biochem. 98 (2006) 931-953
189. Taylor-Papadimitriou J., Burchell J.M., Plunkett T., Graham R., Correa I., Miles D., and Smith M. MUC1 and the immunobiology of cancer. J. Mammary Gland Biol. Neoplasia 7 (2002) 209-221
190. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002) 442-454
191. Thomas G.J., Nystrom M.L., and Marshall J.F. Alphavbeta6 integrin in wound healing and cancer of the oral cavity. J. Oral Pathol. Med. 35 (2006) 1-10
192. Thomsen P., Rudenko O., Berezin V., and Norrild B. The HPV-16 E5 oncogene and bafilomycin A(1) influence cell motility. Biochim. Biophys. Acta 1452 (1999) 285-295
193. Tian B., Li Y., Ji X.N., Chen J., Xue Q., Ye S.L., Liu Y.K., and Tang Z.Y. Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential. J. Cancer Res. Clin. Oncol. 131 (2005) 80-86
194. Tripuraneni J., Koutsouris A., Pestic L., De Lanerolle P., and Hecht G. The toxin of diarrheic shellfish poisoning, okadaic acid, increases intestinal epithelial paracellular permeability. Gastroenterology 112 (1997) 100-108
195. Tsai C.N., Tsai C.L., Tse K.P., Chang H.Y., and Chang Y.S. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc. Natl. Acad. Sci. USA 99 (2002) 10084-10089
196. Valle G.F., and Banks L. The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells. J. Gen. Virol. 76 (1995) 1239-1245
197. Vandenbunder B., Pardanaud L., Jaffredo T., Mirabel M.A., and Stehelin D. Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo. Development 107 (1989) 265-274
198. Varner J.A., and Cheresh D.A. Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. Important Adv. Oncol. (1996) 69-87
199. Wakisaka N., Kondo S., Yoshizaki T., Murono S., Furukawa M., and Pagano J.S. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol. Cell Biol. 24 (2004) 5223-5234
200. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
201. Wang D., Liebowitz D., and Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43 (1985) 831-840
202. Wang J.F., Ganju R.K., Liu Z.Y., Avraham H., Avraham S., and Groopman J.E. Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor. Blood 90 (1997) 3507-3515
203. Wang J.F., Zhang X.F., and Groopman J.E. Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration. J. Biol. Chem. 276 (2001) 41950-41957
204. Watson R.A., Thomas M., Banks L., and Roberts S. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J. Cell Sci. 116 (2003) 4925-4934
205. Watt F.M. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J. 21 (2002) 3919-3926
206. Wheelock M.J., and Johnson K.R. Cadherins as modulators of cellular phenotype. Annu. Rev. Cell Dev. Biol. 19 (2003) 207-235
207. White M.K., Gordon J., Reiss K., Del Valle L., Croul S., Giordano A., Darbinyan A., and Khalili K. Human polyomaviruses and brain tumors. Brain Res. Brain Res. Rev. 50 (2005) 69-85
208. Wilson J.B., Bell J.L., and Levine A.J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15 (1996) 3117-3126
209. Winder S.J., and Ayscough K.R. Actin-binding proteins. J. Cell Sci. 118 (2005) 651-654
210. Wozniak M.A., Modzelewska K., Kwong L., and Keely P.J. Focal adhesion regulation of cell behavior. Biochim. Biophys. Acta 1692 (2004) 103-119
211. Wu C., Chung A.E., and McDonald J.A. A novel role for alpha 3 beta 1 integrins in extracellular matrix assembly. J. Cell. Sci. 108 (1995) 2511-2523
212. Xu L., and Deng X. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of μ- and m-calpain in association with increased secretion, cell migration, and invasion. J. Biol. Chem. 279 (2004) 53683-53690
213. Xu L., and Deng X. Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of μ- and m-calpains. J. Biol. Chem. 281 (2006) 4457-4466
214. Xu L., and Deng X. Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of μ- and m-calpains. J. Biol. Chem. 281 (2006) 35567-35575
215. Yanez-Mo M., Alfranca A., Cabanas C., Marazuela M., Tejedor R., Ursa M.A., Ashman L.K., de Landazuri M.O., and Sanchez-Madrid F. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J. Cell Biol. 141 (1998) 791-804
216. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., and Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 (2004) 927-939
217. Yano Y., Sakon M., Kambayashi J., Kawasaki T., Senda T., Tanaka K., Yamada F., and Shibata N. Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1/2 A inhibitors okadaic acid and calyculin A. Biochem. J. 307 (1995) 439-449
218. Yoshiura K., Kanai Y., Ochiai A., Shimoyama Y., Sugimura T., and Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA 92 (1995) 7416-7419
219. Yoshizaki T. Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1. Histol. Histopathol. 17 (2002) 845-850
220. Young L.S., and Rickinson A.B. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4 (2004) 757-768
221. Young M.R., Kolesiak K., and Meisinger J. Protein phosphatase-2A regulates endothelial cell motility and both the phosphorylation and the stability of focal adhesion complexes. Int. J. Cancer 100 (2002) 276-282
222. Young M.R., Liu S.W., and Meisinger J. Protein phosphatase-2A restricts migration of Lewis lung carcinoma cells by modulating the phosphorylation of focal adhesion proteins. Int. J. Cancer 103 (2003) 38-44
223. Zhai Y., Hotary K.B., Nan B., Bosch F.X., Munoz N., Weiss S.J., and Cho K.R. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res. 65 (2005) 6543-6550
224. Zhang X., Groopman J.E., and Wang J.F. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J. Cell. Physiol. 202 (2005) 205-214
225. Zhang X., Wang J.F., Chandran B., Persaud K., Pytowski B., Fingeroth J., and Groopman J.E. Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection. J. Biol. Chem. 280 (2005) 26216-26224
226. Zhang Z., Morla A.O., Vuori K., Bauer J.S., Juliano R.L., and Ruoslahti E. The alpha v beta 1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin. J. Cell Biol. 122 (1993) 235-242
227. Zhang Z.W., He Z.M., Zhou M., Ding W., Yu Y.H., and Chen Z.C. Mechanism of migration in CNE2 cells promoted by EBV-LMP1. Zhong Nan Da Xue Xue Bao Yi Xue Ban 31 (2006) 470-474 (Article in Chinese)
228. zur Hausen H. Viruses in human cancers. Science 254 (1991) 1167-1173
229. zur Hausen H. Oncogenic DNA viruses. Oncogene 20 (2001) 7820-7823